Neuberger Berman Group LLC Bio Techne Corp Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 3,574,819 shares of TECH stock, worth $276 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

3,574,819

Holding current value

$276 Million

% of portfolio

0.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$65.98 - $77.09 $236 Million - $276 Million	3,574,819 New	3,574,819 $252 Million
Q4 2023 Feb 09, 2024	SELL	$52.83 - $78.22 $1.66 Million - $2.46 Million	-31,393 Reduced 0.84%	3,692,675 $285 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $3.63 Million - $4.8 Million	-53,692 Reduced 1.42%	3,724,068 $253 Million
Q2 2023 Aug 11, 2023	SELL	$73.76 - $85.98 $20.1 Million - $23.5 Million	-272,855 Reduced 6.74%	3,777,760 $308 Million
Q1 2023 May 12, 2023	SELL	$71.62 - $86.62 $6 Million - $7.26 Million	-83,776 Reduced 2.03%	4,050,615 $301 Million

Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $250 Million - $1.09 Billion	3,098,731 Added 299.2%	4,134,391 $343 Million
Q3 2022 Nov 15, 2022	SELL	$282.54 - $391.85 $2.86 Million - $3.97 Million	-10,129 Reduced 0.97%	1,035,660 $294 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $9.23 Million - $12.9 Million	-28,616 Reduced 2.66%	1,045,789 $363 Million
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $7.88 Million - $10.9 Million	-22,266 Reduced 2.03%	1,074,405 $459 Million
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $13.4 Million - $15.5 Million	-29,450 Reduced 2.62%	1,096,671 $560 Million
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $9.19 Million - $11.1 Million	-20,658 Reduced 1.8%	1,126,121 $539 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $13.4 Million - $15.6 Million	-34,589 Reduced 2.93%	1,146,779 $512 Million
Q1 2021 May 13, 2021	SELL	$314.62 - $411.0 $28 Million - $36.6 Million	-88,943 Reduced 7.0%	1,181,368 $448 Million
Q4 2020 Feb 10, 2021	SELL	$246.9 - $321.87 $6.4 Million - $8.34 Million	-25,919 Reduced 2.0%	1,270,311 $402 Million
Q3 2020 Nov 12, 2020	SELL	$232.22 - $282.96 $8.15 Million - $9.93 Million	-35,076 Reduced 2.63%	1,296,230 $321 Million
Q2 2020 Aug 13, 2020	SELL	$185.43 - $279.56 $4.31 Million - $6.5 Million	-23,252 Reduced 1.72%	1,331,306 $351 Million
Q1 2020 May 14, 2020	SELL	$161.17 - $221.51 $5.5 Million - $7.56 Million	-34,110 Reduced 2.46%	1,354,558 $257 Million
Q4 2019 Feb 12, 2020	SELL	$189.68 - $222.09 $1.73 Million - $2.02 Million	-9,104 Reduced 0.65%	1,388,668 $305 Million
Q3 2019 Nov 13, 2019	BUY	$183.56 - $216.72 $7.36 Million - $8.68 Million	40,072 Added 2.95%	1,397,772 $274 Million
Q2 2019 Aug 13, 2019	SELL	$188.72 - $215.43 $6.16 Million - $7.03 Million	-32,620 Reduced 2.35%	1,357,700 $283 Million
Q1 2019 May 13, 2019	SELL	$136.09 - $200.44 $4.77 Million - $7.02 Million	-35,041 Reduced 2.46%	1,390,320 $276 Million
Q4 2018 Feb 12, 2019	SELL	$132.75 - $203.8 $13.7 Million - $21 Million	-103,257 Reduced 6.75%	1,425,361 $206 Million
Q3 2018 Nov 13, 2018	SELL	$147.44 - $204.11 $8.2 Million - $11.4 Million	-55,636 Reduced 3.51%	1,528,618 $312 Million
Q2 2018 Aug 13, 2018	SELL	$144.9 - $165.58 $8.88 Million - $10.1 Million	-61,253 Reduced 3.72%	1,584,254 $234 Million
Q1 2018 May 08, 2018	SELL	$131.46 - $151.04 $4.99 Million - $5.73 Million	-37,948 Reduced 2.25%	1,645,507 $249 Million
Q4 2017 Feb 14, 2018	SELL	$121.17 - $134.75 $12.1 Million - $13.4 Million	-99,536 Reduced 5.58%	1,683,455 $218 Million
Q3 2017 Nov 15, 2017	BUY	$113.59 - $123.78 $203 Million - $221 Million	1,782,991	1,782,991 $216 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.03B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Bio Techne Corp Transaction History